SciELO - Scientific Electronic Library Online

vol.82 issue3High frequency of depressive symptoms in caregivers of pediatric patients on peritoneal dialysis and hemodialysis in a public Hospital in LimaFemale dysthymia and the phenomena of love and heartbreak author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista de Neuro-Psiquiatría

Print version ISSN 0034-8597


STUCCHI-PORTOCARRERO, Santiago. Is the division between "classic" and "atypical" antipsychotics still valid?. Rev Neuropsiquiatr [online]. 2019, vol.82, n.3, pp.209-217. ISSN 0034-8597.

The development of "atypical" or "second generation" antipsychotics, generated great expectations from the 1990s, as they were attributed more efficacy and tolerability than the "typical", "classic" or "first generation" antipsychotics, due mostly to the impact of a huge advertising campaign by the pharmaceutical industry. However, different studies have not been able to prove, in a categorical way, the alleged superiority of that group of drugs in terms of efficacy, prevention of relapses or production of adverse effects. On the other hand, the classification of "classic" and "atypical" antipsychotics cannot be supported either by factors such as chemical structure, mechanisms of action, costs or years in the market, , given the heterogeneity that both groups exhibit. For such reasons, it is suggested that the existing dichotomy should be ruled out.

Keywords : antipsychotics; neuroleptics; pharmaceutical industry; schizophrenia.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License